News and Announcements
Baxta, Australia’s #1 social networking pet app opens up a pet-friendly world of opportunities
- Published April 13, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Baxta, Australia’s #1 social networking pet app, announces that it has over 25,000 users and has created more than 14,000 forms of user-generated content.
The pet industry in Australia is worth $13 billion. Baxta powered by its newly revamped ‘Discover’ feature connects and supports today’s fast-growing generation of pets, pet owners, and pet-friendly businesses. Along with a vibrant social media function, Baxta simplifies the world of pet content, expert pet advice and resources by putting them all at our users’ fingertips.
The fact is, prioritising business discovery always helps interested customers uncover and interact with a business, cultivate relationships, and grow sales and foot traffic. With pet spending rising, Baxta’s Discover feature enables businesses to connect with a growing pet community by combining MapKit and CoreLocation frameworks integrated with Apple Maps for easy viewing. The result is a rich, vibrant directory of pet-friendly destinations, businesses, and services with helpful captions and images. Geolocation features are also implemented to showcase pet-friendly venues around the user’s area so that pet parents can sort venues from the closest to the farthest away from them.
Baxta’s four-tiered business pricing approach ranges from a basic free listing to a premium option that gives businesses more visibility and higher search rankings, click-to-call, special offers and the opportunity to interact with our community.
About The Company
Launched in August 2020, Baxta is a social networking platform and app that connects and supports Australia’s fast-growing generation of pet owners and pets with each other, including pet-friendly businesses and communities that serve all animals.
The opportunity
In Australia, 69% of households own a pet, a total of 29 million pets. Almost 50% own at least one dog, and 30% own a cat (Animal Medicines Australia survey). Households are estimated to spent more than $12.2 billion on pet products and services last year, up 42 per cent since 2013.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
